- By seeing a GP who arranges the referral to the physiotherapy service. - By seeing a Physiotherapist directly in a GP practice - Other (please provide details) 7) Please confirm/deny that patients can access physiotherapy for their existing long-term condition through each of the following pathways: - By referring themselves directly to the physiotherapy service - By seeing a GP and being given the details to book a physiotherapy appointment themselves - By seeing a GP who arranges the referral to the physiotherapy service. - By seeing a Physiotherapist directly in a GP practice - Other (please provide details) 4) Please confirm/deny whether patients can be a) re-referred into or b) self-refer back into any services confirmed in request one. – Patients can be back in to the service following discharge if the referral criteria is met 5) Please provide details of the staffing make-up of any services confirmed in request one. – we do not hold this information. 6) Please confirm/deny that patients can access MSK physiotherapy through each of the following pathways: - By referring themselves directly to the physiotherapy service - Yes - By seeing a GP and being given the details to book a physiotherapy appointment themselves - Yes - By seeing a GP who arranges the referral to the physiotherapy service. - Yes - By seeing a Physiotherapist directly in a GP practice - No - Other (please provide details) 7) Please confirm/deny that patients referred
relation to the number of individual biologic drugs in use/on formulary at any one time for use within Rheumatoid Arthritis? -What restrictions (if any) does the CCG’s formulary have in place in relation to the number of individual biologic drugs in use/on formulary at any one time for use within Psoriatic Arthritis? -Finally, could you provide a link/attach to your response the latest versions of your patient pathways for Crohn’s Disease and Psoriatic Arthritis? 2014 TA342 in July 2015 indications applicable locally and confirmed Red ( hospital only) Red prescribing classification. TA352 in September 2015 applicable locally and included. -What restrictions (if any) does the CCG’s formulary have in place in relation to the number of individual biologic drugs in use/on formulary at any one time for use within Rheumatoid Arthritis? Prescribed in line with NICE guidance and as per formulary. No additional restriction. -What restrictions (if any) does the CCG’s formulary have in place in relation to the number of individual biologic drugs in use/on formulary at any one time for use within Psoriatic Arthritis? Prescribed in line with NICE guidance and as per formulary. No additional restriction. -Finally, could you provide a link/attach to your response the latest versions of your patient pathways for Crohn’s Disease and Psoriatic Arthritis? Follow national NICE pathways. FoI No: 567 – received 14 July 2016 1. According to your current IVF treatment policy: a. How many cycles of IVF do you offer to eligible patients? b. Do you fund a full cycle of IVF, as defined by NICE, which includes replacement of all frozen embryos? If not how many frozen embryo transfers do you fund? According to your current IVF treatment policy: a. How many cycles of IVF do you offer to eligible patients? 2 b. Do you fund a full cycle of IVF, as defined by NICE, which includes replacement of
may use a different name for it. If you share the same policy with other CCGs, it would be helpful if you could list those other CCGs and liaise with them and/or your Commissioning Support Unit to only provide one copy rather than duplicating effort. FoI No: 571 – received 19 July 2016 1. Does the CCG Commission NHS Arthroplasty services? 2. a) What is the total number of hip replacement operations your Trust has commissioned over the following years: 2011, 2012, 2013, 2014, 2015. Please provide 5 answers, in calendar years. b) What is the total number of hip replacement revision operations your Trust has commissioned over the following years: 2011, 2012, 2013, 2014, 2015. Please provide 5 answers, in calendar years. c) What is the total number of knee replacements your Trust has commissioned over the following years: 2011, 2012, 2013, 2014, 2015. Please provide 5 answers, in calendar d) What is the total number of knee replacement revisions your Trust has commissioned over the following years: 2011, 2012, 2013, 2014, 2015. Please provide 5 answers, in calendar 3. a) What is the average length of time patients wait for a hip replacement procedure from diagnosis to treatment? b) What is the average length of time patients wait for a hip replacement revision from diagnosis to treatment? c) What is the average length of time patients wait for a knee replacement from diagnosis to treatment? d) What is the average length of time patients wait for a knee replacement revision from 1. Does the CCG Commission NHS Arthroplasty services? – YES Information can only be provided since the CCG was established in April 2013 2. a) What is the total number of hip replacement operations your Trust has commissioned over the following years: 2011, 2012, 2013, 2014, 2015. Please provide 5 answers, in calendar years. 13/14 – 324 14/15 – 365 15/16 – 293 b) What is the total number of hip replacement revision operations your Trust has commissioned over the following years: 2011, 2012, 2013, 2014, 2015. Please provide 5 answers, in calendar years. 13/14 – 47 14/15 – 37 15/16 – 31
neurological conditions. If confirmed, please state which of the conditions listed in Annex A are included in these services. 2. Please confirm whether your CCG has made an assessment of the prevalence of neurological conditions in your area. If confirmed, please provide details of the assessment, including the individual conditions listed. 3. Please confirm whether your CCG has made an assessment of the number of people using neurological services in your area. If confirmed, please provide details of the assessment, including the individual conditions assessed. 4. Please confirm whether your CCG has made an assessment of: i) the total costs of neurological services in your area. If confirmed, please provide details of the assessment ii) the per patient costs of neurological services in your area. If confirmed, please provide details of the assessment. 5. Please confirm whether your CCG collects data on the experience of patients using neurological services. If confirmed, please provide details. 6. Please confirm whether your CCG: i) includes service users in on the commissioning of neurological services, ii) includes service users in providing ongoing feedback on the quality of neurological services, iii) takes any specific measures to support participation of people with neurological conditions. If confirmed, please state which of the conditions listed in Annex A are included in these services. NHS Barnsley CCG does commission services for people with neurological conditions. NHS England also commission services for people with neurological conditions where these are deemed to be specialised. Services commissioned cover the conditions set out in Annex A. 2. Please confirm whether your CCG has made an assessment of the prevalence of neurological conditions in your area. If confirmed, please provide details of the assessment, including the individual conditions listed. The CCG has not undertaken a specific assessment of the prevalence of neurological conditions in the area. 3. Please confirm whether your CCG has made an assessment of the number of people using neurological services in your area. If confirmed, please provide details of the assessment, including the individual conditions assessed. The CCG has not undertaken a specific assessment of the number of people using neurological services in the area. Contracts with service providers are however based upon current activity levels and trends over recent years to ensure service capacity is suffiecient to meet needs. Neuro Rehab service is commissioned by Barnsley CCG but NHS England holds the rest of the details. 4. Please confirm whether your CCG making